Irritable Bowel Syndrome Clinical Trials in Barcelona
4 recruitingBarcelona, Spain
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
DiarrheaIrritable Bowel Syndrome
Eli Lilly and Company531 enrolled88 locationsNCT07545759
Recruiting
Not Applicable
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl330 enrolled12 locationsNCT06681012
Recruiting
Phase 3
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
IBS - Irritable Bowel SyndromeIBS-D (Diarrhea-predominant)IBS, Mixed Symptoms
Biocodex406 enrolled10 locationsNCT07168434
Recruiting
Not Applicable
Visible Abdominal Distension
Functional BloatingDyspepsiaIrritable Bowel Syndrome
Hospital Universitari Vall d'Hebron Research Institute100 enrolled7 locationsNCT06369753